C

Cue Biopharma
D

CUE

32.110
USD
-1.43
(-4.31%)
مفتوح الان
حجم التداول
1,581
الربح لكل سهم
-0
العائد الربحي
-
P/E
-7
حجم السوق
134,452,979
المقالات
المزيد

العنوان: Cue Biopharma Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate forautoimmune diseases.